Our Minor, Novel & Synthetic Cannabinoid series continues with Part IV highlighting the occupational health and safety considerations to make during the manufacture of cannabinoids and provide recommendations for mitigating risk. There is no mistaking that manufacturing cannabinoids is here to stay. It is more and more prevalent to see historically plant/naturally derived bulk ingredients […]
Find out more »NCIA is leading the cannabis industry's unified and coordinated campaign to ensure our business sector is treated fairly and has the opportunity to reach its full potential. Now - more than ever - is the time to invest in your business and the future of the industry by becoming a member.
This site uses cookies. By using this site or closing this notice, you agree to the use of cookies and our privacy policy.